Genomics

Intellectia 5 candidates

Genomics is the study of genomes, encompassing the analysis of DNA sequences and their functions. Key technologies include CRISPR gene editing, next-generation sequencing, and bioinformatics, driving innovations in personalized medicine and genetic therapies.

Name

Price

%Chg

Market Cap

ILMN

Illumina Inc

$134.92

+0.04%

20.62B

CRSP

CRISPR Therapeutics AG

$56.25

-0.76%

5.36B

EDIT

Editas Medicine Inc

$2.44

-3.56%

238.19M

NTLA

Intellia Therapeutics Inc

$9.14

+1.33%

1.06B

PACB

Pacific Biosciences of California Inc

$2.12

+0.00%

640.04M

This list is generated based on data from one or more third party data providers. It is provided for informational purposes only by Intellectia.AI, and is not investment advice or a recommendation. Intellectia does not make any warranty or guarantee relating to the accuracy, timeliness or completeness of any third-party information, and the provision of this information does not constitute a recommendation.

Popular Themes

Pricing Power

18 candidates

-0.76%

Israeli-Palestinian Conflict

Aging U.S. Population

Frequently Asked Questions

What is the Genomics stock list?

Which stocks are included in the theme of Genomics?

The list includes top performers like Illumina Inc (ILMN.O), CRISPR Therapeutics AG (CRSP.O), Editas Medicine Inc (EDIT.O), Intellia Therapeutics Inc (NTLA.O), among others. These stocks are representative examples from Genomics stock list.